RU 58841 is a drug that is used to treat hypertension. The drug is a nonsteroidal antiandrogen and vasodilator. This means that it opens up the blood vessels in your body to help them relax and re-grow. It is also used for hair loss.
RU 58841 is a nonsteroidal antiandrogen
RU 58841 is a new topically active antiandrogen that is thought to be useful for topical treatment of androgen-dependent skin disorders. It has strong affinity for androgen receptors in the hamster prostate and flank organ. It is considered to be a promising new topical drug for the treatment of acne.
RU 58841 has been evaluated in various animal models of androgen-dependent skin disorders. In a human prostate PC3 cell line, RU58841 was shown to have antagonism to wild-type ARs. This resulted in a dose-dependent regression of the F.O. area, with a 60% reduction in sebaceous gland size. It was also shown to have a marginal agonist activity.
It causes hair follicles to re-grow
RU58841 is a topical solution that helps stimulate new hair growth. The ingredient is designed to protect scalp hairs from the ravages of DHT, which is the main culprit behind male pattern baldness (MPB) and other hair loss woes. The compound possesses impressive topical efficacy, according to the Journal of Steroid Bio-Chemistry and Molecular Biology. It also has selectivity, as demonstrated by the fact that it appears to be more effective on male than female subjects.
RU58841 is not the only baldness treatment on the market. Other candidates include finasteride and dutasteride. The latter reportedly prevents DHT levels from being triggered by estrogen, a hormone favored by women. It may even be capable of restoring damaged hair follicles, although this has yet to be demonstrated in the clinical setting.
It works better when applied with another hair loss treatment
RU58841, or PSK-3841, is a chemical that inhibits DHT production, locally in the scalp. While it hasn’t been officially tested in humans, it has been proven to work on animals. In fact, a study published in the Journal of Dermatology investigated the effects of RU58841.
In short, RU58841 is a non-steroidal anti-androgen that works by inhibiting DHT production. DHT is a male hormone that attaches to hair follicles, causing them to shrivel. Dutasteride, another anti-androgen, blocks DHT from being produced. RU58841 isn’t approved by the FDA, but it’s available in the US as a research chemical.
RU58841 comes in powder or liquid form. The powder is typically mixed with kb, propylene glycol, or ethanol. The liquid is dispensed through a dripper. It’s usually sold in 5 gram bags for around $70.
Pre-made RU58841 solutions are not guaranteed
RU58841, also known as cyanonilutamide, is an anti-androgenic agent that works by blocking the synthesis of DHT in the scalp. In animal studies, RU58841 was effective at treating hair loss and regrowing hair in mice and hamsters.
RU58841 was initially synthesized by French scientists in the early 1990s. In 2002, ProStrakan acquired the rights to the drug after a merger with Roussel-UCLAF. ProStrakan conducted a human trial on the drug and the results were overwhelmingly positive.
In addition to treating androgenic alopecia, RU58841 has been found to be effective in the treatment of acne and hirsutism. However, the compound can also cause a number of side effects, including erectile dysfunction and skin irritation.
RU 58841 is not declared legal or approved by FDA
RU 58841 is an anti-androgen that was first developed by French researchers. It was considered a promising drug in the 1990s, but it has only recently begun to be tested in humans. It is not approved by the US Food and Drug Administration (FDA) for human use, but it is legal for research and testing purposes.
RU58841 is a non-steroidal antiandrogenic compound that acts as a strong agonist to androgen receptors in hair follicles. It prevents the binding of DHT to these receptors. DHT is a byproduct of the testosterone metabolism in the testes. Using RU58841 prevents hair loss and promotes the growth of new hair follicles.